{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:06:29Z","timestamp":1792069589369,"version":"4.4.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","award":["PAMEQ Program\u2014#004\/2019"],"award-info":[{"award-number":["PAMEQ Program\u2014#004\/2019"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","award":["PAPAC Program\u2014#005\/2019"],"award-info":[{"award-number":["PAPAC Program\u2014#005\/2019"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","award":["Pr\u00f3-Estado Program\u2014#002\/2008, #007\/2018 and #005\/2019"],"award-info":[{"award-number":["Pr\u00f3-Estado Program\u2014#002\/2008, #007\/2018 and #005\/2019"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PROCAD-Amaz\u00f4nia 2018 Program\u2014#88881.200581\/2018-01"],"award-info":[{"award-number":["PROCAD-Amaz\u00f4nia 2018 Program\u2014#88881.200581\/2018-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sickle Cell Anemia (SCA) is the most common genetic disorder around the world. The mutation in the \u03b2-globin gene is responsible for a higher hemolysis rate, with further involvement of immunological molecules, especially cytokines, chemokines, growth factors, and anaphylatoxins. These molecules are responsible for inducing and attracting immune cells into circulation, thus contributing to increases in leukocytes and other pro-inflammatory mediators, and can culminate in a vaso-occlusive crisis (VOC). This study aimed to characterize the levels of these molecules in SCA patients in different clinical conditions in order to identify potential hallmarks of inflammation in these patients. An analytical prospective study was conducted using the serum of SCA patients in steady-state (StSt; <jats:italic>n<\/jats:italic> = 27) and VOC (<jats:italic>n<\/jats:italic> = 22), along with 53 healthy donors (HD). Samples from the VOC group were obtained on admission and on discharge, in the convalescent phase (CV). Levels of chemokines (CXCL8, CXCL10, CL2, CLL3, CCL4, CL5, and CCL11), cytokines (IL-1\u03b2, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-10, IL-12p70, IL-13, IL-17A, TNF-\u03b1, and IFN-\u03b3) and growth factors (VEGF, FGFb, PDGF-BB, GM-CSF, and G-CSF) were measured using a Luminex assay, and anaphylatoxins (C3a, C4a, and C5a) were measured using Cytometric Bead Array. SCA patients in StSt showed a pro-inflammatory profile, and were indicated as being higher producers of CCL2, IL-1\u03b2, IL-12p70, IFN-\u03b3, IL-17A, and GM-CSF, while VOC is highlighted by molecules IL-4 and IL-5, but also IL-2, IL-7, PDGF-BB, and G-CSF. PDGF-BB and IL-1ra seemed to be two important hallmarks for the acute-to-chronic stage, due to their significant decrease after crisis inflammation and statistical difference in VOC and CV groups. These molecules show higher levels and a strong correlation with other molecules in VOC. Furthermore, they remain at higher levels even after crisis recovery, which suggest their importance in the role of inflammation during crisis and participation in immune cell adhesion and activation. These results support a relevant role of cytokines, neutrophil and monocytes, since these may act as markers of VOC inflammation in SCA patients.<\/jats:p>","DOI":"10.3389\/fimmu.2021.559925","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T05:04:36Z","timestamp":1615439076000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Alexander Leonardo","family":"Silva-Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja Pinto","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evil\u00e1zio Cunha","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanny","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Monteiro","family":"Tarrag\u00f4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson Abrahim","family":"Fraiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Souza","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence Rodrigues","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich Vinicius","family":"De Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson Guimar\u00e3es","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Malheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/CH-189013","article-title":"Hypercoagulable state in sickle cell disease","volume":"68","author":"Faes","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2018","journal-title":"Ann Rev Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1590\/S1516-84842000000100003","article-title":"Interferentes eritrocit\u00e1rios e ambientais na anemia falciforme","volume":"22","author":"Naoum","year":"2000","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2141.2007.06794.x","article-title":"Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia?","volume":"139","author":"Vekilov","year":"2007","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1590\/S1676-24442003000100011","article-title":"Aspectos moleculares da anemia falciforme","volume":"39","author":"Neto","year":"2003","journal-title":"J Bras Patol Med Lab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4585704","DOI":"10.1155\/2020\/4585704","article-title":"Sickle cell anemia patients display an intricate cellular and serum biomarker network highlighted by TCD4+CD69+ lymphocytes, IL-17\/MIP-1\u03b2, IL-12\/VEGF, and IL-10\/IP-10 axis","volume":"2020","author":"Garcia","year":"2020","journal-title":"J Immunol Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1182\/blood-2014-04-560813","article-title":"Sickle cell disease increases high mobility group box 1: a novel mechanism of in flammation","volume":"124","author":"Xu","year":"2014","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1152\/ajpcell.00401.2005","article-title":"High mobility group box 1 protein interacts with multiple Toll-like receptors","volume":"290","author":"Park","year":"2006","journal-title":"Am J Physiol Cell Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3324\/haematol.2019.239343","article-title":"Thromboinflammatory mechanisms in sickle cell disease\u2014challenging the hemostatic balance","volume":"105","author":"Conran","year":"2020","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tracli.2019.02.008","article-title":"Complement activation during intravascular hemolysis: implication for sickle cell disease and hemolytic transfusion reaction","volume":"26","author":"Merle","year":"2019","journal-title":"Transfus Clin Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/bjh.12445","article-title":"Association between plasma free haem and incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease","volume":"162","author":"Adisa","year":"2013","journal-title":"Br J Haematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.hemonc.2015.11.002","article-title":"Clinical events and their relation to the tumor necrosis factor-alpha and interleukin-10 genotypes in Sickle-Cell- Anemia patients","volume":"9","author":"Cavalcante","year":"2016","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2019.154933","article-title":"Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises","volume":"127","author":"Barbu","year":"2020","journal-title":"Cytokine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/20469047.2018.1519988","article-title":"Acute chest syndrome in sickle cell anaemia : higher serum levels of interleukin-8 and highly sensitive C-reactive proteins are associated with impaired lung function","volume":"38","author":"Adegoke","year":"2018","journal-title":"Paediatr Int Child Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2141.2011.08961.x","article-title":"Biomarkers in sickle cell disease","volume":"156","author":"Rees","year":"2011","journal-title":"Br J Haematol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cyto.2009.10.002","article-title":"Plasma interleukin-1\u03b2 concentration is associated with stroke in sickle cell disease","volume":"49","author":"Asare","year":"2010","journal-title":"Cytokine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01882","article-title":"An immunological stairway to severe tissue complication assembly in bothrops atrox snakebites","volume":"10","author":"Ibiapina","year":"2019","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/875647939000600106","article-title":"Interpretation of the correlation coefficient: a basic review","volume":"6","author":"Taylor","year":"1990","journal-title":"J Diagnostic Med Sonogr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/10245330310001604719","article-title":"Cytokines in sickle cell disease","volume":"8","author":"Pathare","year":"2003","journal-title":"Hematology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1179\/1607845415Y.0000000048","article-title":"Association of homocysteine and inflammatory-related molecules in sickle cell anemia","volume":"21","author":"Vilas-boas","year":"2015","journal-title":"Hematology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cyto.2013.11.012","article-title":"Cytokine evaluation of Th17 related cytokines associated with clinical and laboratorial parameters in sickle cell anemia patients with leg ulcers","volume":"65","author":"da Silva","year":"2014","journal-title":"Cytokine."},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1684\/ecn.2013.0328","article-title":"Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition","volume":"24","author":"Keikhaei","year":"2013","journal-title":"Eur Cytokine Netw"},{"key":"B28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.archoralbio.2012.11.006","article-title":"Serum cytokine profile among Brazilian children of African descent with periodontal inflammation and sickle cell anaemia","volume":"58","author":"Veiga","year":"2013","journal-title":"Arch Oral Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/CVI.00145-09","article-title":"Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis","volume":"17","author":"Musa","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cyto.2014.11.030","article-title":"Cytokine serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition","volume":"72","author":"Sarray","year":"2015","journal-title":"Cytokine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am J Hematol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s002770000173","article-title":"The role of cytokines in sickle cell disease","volume":"79","author":"Makis","year":"2000","journal-title":"Ann Hematol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/CIRCRESAHA.116.304577","article-title":"Iron, inflammation and early death with sickle cell disease","volume":"116","author":"Van Beers","year":"2015","journal-title":"Circ Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0065-2423(09)48005-3","article-title":"Proinflammatory cytokines in crp baseline regulation","volume":"48","author":"Eklund","year":"2009","journal-title":"Adv Clin Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.sjbs.2014.09.005","article-title":"Clinical biomarkers in sickle cell disease","volume":"22","author":"Damanhouri","year":"2015","journal-title":"Saudi J Biol Sci"},{"key":"B37","volume-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2015"},{"key":"B38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.molmed.2016.01.004","article-title":"Heme: modulator of plasma systems in hemolytic diseases","volume":"22","author":"Roumenina","year":"2016","journal-title":"Trends Mol Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"B41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3324\/haematol.2017.174201","article-title":"In vitro evidence of complement activation in patients with sickle cell disease","volume":"102","author":"Gavriilaki","year":"2017","journal-title":"Haematologica"},{"key":"B42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/1076029611420992","article-title":"Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell Disease","volume":"18","author":"Qari","year":"2012","journal-title":"Clin Appl Thromb"},{"key":"B43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/153537020523000109","article-title":"Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease","volume":"230","author":"Hibbert","year":"2004","journal-title":"Exp Biol Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int Anesth Clin"},{"key":"B46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cyto.2016.03.016","article-title":"Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell","volume":"83","author":"Pitanga","year":"2016","journal-title":"Cytokine."},{"key":"B47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molimm.2011.12.012","article-title":"Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-kB signaling pathway","volume":"50","author":"Safaya","year":"2012","journal-title":"Mol Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.559925\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T05:04:40Z","timestamp":1615439080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.559925\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2021.559925"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.559925","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"article-number":"559925"}}